Lucyd, Inc (LUCY) vs enVVeno Medical Corporation (NVNO)

A side-by-side comparison of Lucyd, Inc and enVVeno Medical Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

LUCY

Lucyd, Inc

$6M

$0.93HealthcareDelayed quote: Oct 6, 2026, 1:44 PM EDT

NVNO

enVVeno Medical Corporation

$6M

$8.00HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT

Total return — LUCY vs NVNO

growth of $100 · dividends reinvested · last 4y

LUCY -99.2% (-70.5%/yr)NVNO -96.1% (-55.7%/yr)NVNO compounded faster over this window

Log scale — wide-divergence pair

LUCY NVNO

LUCY vs NVNO: by the numbers

•LUCY is the larger company ($6M vs $6M market cap).
•Both run net losses; NVNO's is the smaller (0.00% vs -225.28% net margin).

Metrics side by side

Valuation

Metric	LUCY	NVNO
P/S ratio	1.72	N/A
P/B ratio	0.85	0.27

Profitability

Metric	LUCY	NVNO
Gross margin	22.79%	0.00%
Operating margin	-319.16%	0.00%
Net margin	-225.28%	0.00%
ROE	-111.42%	-76.07%
ROIC	-122.15%	-80.65%

Growth (annualized)

Metric	LUCY	NVNO
Revenue CAGR (5Y)	64.52%	N/A
Total return CAGR (5Y)	N/A	-52.99%

Go deeper

Full LUCY analysis Full NVNO analysis Interactive comparison tool

Dig into the metrics

Lucyd ROE enVVeno Medical ROE Lucyd operating margin enVVeno Medical operating margin Lucyd revenue growth enVVeno Medical revenue growth Lucyd free cash flow enVVeno Medical free cash flow

Lucyd & enVVeno Medical appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.